Longatto Filho Adhemar, Oliveira Tiago Gil, Pinheiro Céline, de Carvalho Marcos Brasilino, Curioni Otávio Alberto, Mercante Ana Maria da Cunha, Schmitt Fernando C, Gattás Gilka Jf
Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
World J Surg Oncol. 2007 Dec 11;5:140. doi: 10.1186/1477-7819-5-140.
Lymphatic vessels are major routes for metastasis in head and neck squamous cell carcinoma (HNSCC), but lymphatic endothelial cells (LECs) are difficult to recognize in tumor histological sections. D2-40 stains podoplanin, a molecule expressed in LECs, however, the potential prognostic usefulness of this molecule is not completely understood in HNSCC. We aimed to investigate the value of assessing peritumoral and intratumoral lymphatic vessel density (LVD) as prognostic marker for HNSCC.
Thirty-one cases of HNSCC were stained for D2-40 and CD31. LVD and blood vessel density (BVD) were assessed by counting positive reactions in 10 hotspot areas at x200 magnification.
D2-40 was specific for lymphatic vessels and did not stain blood vascular endothelial cells. LECs showed more tortuous and disorganized structure in intratumoral lymphatic vessels than in peritumoral ones. No statistical differences were observed between peritumoral-LVD and intratumoral-LVD or between peritumoral-BVD and intratumoral-BVD. Tumor D2-40 staining was positively associated with lymphatic vessel invasion (p = 0.011).
LVD is a powerful marker for HNSCC prognosis. We found significant differences in peritumoral and intratumoral D2-40 immunoreactivity, which could have important implications in future therapeutic strategies and outcome evaluation.
淋巴管是头颈部鳞状细胞癌(HNSCC)转移的主要途径,但在肿瘤组织切片中难以识别淋巴管内皮细胞(LECs)。D2-40可对足板蛋白进行染色,足板蛋白是一种在LECs中表达的分子,然而,在HNSCC中该分子潜在的预后价值尚未完全明确。我们旨在研究评估肿瘤周围和肿瘤内淋巴管密度(LVD)作为HNSCC预后标志物的价值。
对31例HNSCC病例进行D2-40和CD31染色。通过在200倍放大倍数下计数10个热点区域的阳性反应来评估LVD和血管密度(BVD)。
D2-40对淋巴管具有特异性,不染色血管内皮细胞。肿瘤内淋巴管中的LECs比肿瘤周围的LECs显示出更曲折和紊乱的结构。肿瘤周围LVD与肿瘤内LVD之间或肿瘤周围BVD与肿瘤内BVD之间未观察到统计学差异。肿瘤D2-40染色与淋巴管浸润呈正相关(p = 0.011)。
LVD是HNSCC预后的有力标志物。我们发现肿瘤周围和肿瘤内D2-40免疫反应性存在显著差异,这可能对未来的治疗策略和结果评估具有重要意义。